FORTE BIOSCIENCES INC (FBRX)
US34962G1094 - Common Stock
Forte Biosciences to Host R&D Day December 3, 2024
Thursday Sector Laggards: Shipping, Biotechnology Stocks
Wednesday Sector Leaders: Education & Training Services, Biotechnology Stocks
Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update
FBRX Stock Earnings: Forte Biosciences Misses EPS for Q2 2024
FBRX stock results show that Forte Biosciences missed analyst estimates for earnings per share the second quarter of 2024.
FBRX Stock Earnings: Forte Biosciences Misses EPS for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Forte Biosciences (NASDAQ:FBRX) just reported results for the second quarter of...
Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
FBRX Stock Earnings: Forte Biosciences Reported Results for Q1 2024
Forte Biosciences just reported results for the first quarter of 2024.
FBRX Stock Earnings: Forte Biosciences Reported Results for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Forte Biosciences (NASDAQ:FBRX) just reported results for the first quarter of ...
Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update
FBRX Stock Earnings: Forte Biosciences Reported Results for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Forte Biosciences (NASDAQ:FBRX) just reported results for the fourth quarter of...
FBRX Stock Earnings: Forte Biosciences Reported Results for Q4 2023
Forte Biosciences just reported results for the fourth quarter of 2023.
Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update
Forte Biosciences rebuke board challengers, re-elect incumbents (NASDAQ:FBRX)
Despite calls or changes to its board, Forte Biosciences (FBRX) shareholders voted to keep the current slate of directors. Read more here.
ISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company’s Upcoming Annual Meeting
Concerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company’s Boardroom
Concerned Stockholders of Forte Biosciences File Definitive Proxy Statement and Send Letter to Stockholders
Forte Biosciences, Inc. Announces Second Quarter 2023 Results and Provides Business Update
Forte Biosciences closes $25M financing, to advance FB-102 in 2024 (NASDAQ:FBRX)
Forte Biosciences (FBRX) said Tuesday it closed a $25 million financing to support the advancement of FB-102. The company said it plans to advance FB-102 into the clinic in 2024
Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules